Effects of artesunate, dihydroartemisinin, and an artesunate- dihydroartemisinin combination against Toxoplasma gondii

American Journal of Tropical Medicine and Hygiene

Volumn 62, Issue 1, 2000, Pages 73-76

  Sarciron, Marie Elisabeth ^a   Saccharin, Charles ^b   Petavy, Anne Françoise ^a   Peyron, François ^c  

^a UNIVERSITÉ LYON 1   (France)

^b HIA Desgenettes   (France)

^c CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; DIHYDROARTEMISININ; PYRIMETHAMINE; SULFADIAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PHASE CONTRAST MICROSCOPY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALIA; ARTESUNATE; PROTOZOA; TOXOPLASMA GONDII;

EID: 0034030445     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.62.73     Document Type: Article

References (20)

1. China Cooperative Research Group on Quinghaosu and its Derivatives as Antimalarials, 1982. The chemistry and synthesis of quinghaosu derivatives. J Tradit Chin Med 2: 9-16.
2. China Cooperative Research Group on Quinghaosu and its Derivatives as Antimalarials, 1982. Clinical studies on the treatment of malaria with quinghaosu and its derivatives. J Tradit Chin Med 2: 45-50.
3. Benakis A, Paris M, Loutan L, Plessas CT, Plessas ST, 1997. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. Am J Trop Med Hyg 56: 17-23.
4. Bich NN, de Vries PJ, van Thien H, Phong TH, Hung LN, Eggelte TE, Anh TK, Kager PA, 1996. Efficacy and tolerance of artemisinin in short combination regimens for the treatment of uncomplicated falciparum malaria. Am J Trop Med Hyg 55: 438-443.
5. Looareesuwan S, Wilairatana P, Vanijanonta S, Pitisuttithum P, Viravan C, Kraisintu K, 1996. Treatment of acute, uncomplicated, falciparum malaria with oral dihydroartemisinin. Ann Trop Med Parasitol 90: 21-28.
6. Meshnick SR, 1994. The mode of action of antimalarial endoperoxides. Trans R Soc Trop Med Hyg 88 (suppl 1): 31-32.
7. Barradell LB, Fitton A, 1995. Artesunate: a review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 40: 714-741.
8. Ou-Yang K, Krug EC, Marr JJ, Berens RL, 1990. Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives. Antimicrob Agents Chemother 34: 1961-1965.
9. Chang HR, Pechère JC, 1988. Arteether, a qinghaosu derivative, in toxoplasmosis. Trans R Soc Trop Med Hyg 82: 867.
10. Brun-Pascaud M, Chau F, Derouin F, Girard PM, 1996. Lack of activity of artemether for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii infections in rat. Parasite 3: 187-189.
11. Suresh K, Howe J, Ng GC, Ho LC, Ramachandran NP, Loh AK, Yap EH, Singh M, 1994. A multiple fission-like mode of asexual reproduction in Blastocystis hominis. Parasitol Res 80: 523-527.
12. Hassan Alin M, Bjorkman A, 1994. Concentration and time dependency of artemisinin efficacy against Plasmodium falciparum in vitro. Am J Trop Med Hyg 50: 771-776.
13. 3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 78: 265-270.
14. Meshnick SR, Thomas A, Ranz A, Xu C-M, Pan H-Z, 1991. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol Biochem Parasitol 49: 181-190.
15. Holfels E, McAuley J, Mack D, Milhous WK, McLeod R, 1994. In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii. Antimicrob Agents Chemother 38: 1392-1396.
16. Cooke DW, Gunther J, Lallinger J, Durack DT, 1987. In vitro sensitivity of Naegleria fowleri to qinghaosu and dihydroqinghaosu. J Parasitol 73: 411-413.
17. Maeno Y, Toyoshima T, Fujioka H, Ito Y, Meshnick SR, Benakis A, Milhous WK, Aikawa M, 1993. Morphologic effects of artemisinin in Plasmodium falciparum. Am J Trop Med Hyg 49: 485-491.
18. Berens RL, Krug EC, Nash PB, Curiel TJ, 1998. Selection and characterization of Toxoplasma gondii mutants resistant to artemisinin. J Infect Dis 177: 1128-1131.
19. Sarciron ME, Lawton Ph, Saccharin C, Pétavy AF, Peyron F, 1997. Effects of 2′,3′-dideoxyinosine on Toxoplasma gondii cysts in mice. Antimicrob Agents Chemother 41: 1531-1536.
20. Sarciron ME, Lawton Ph, Pétavy AF, Peyron F, 1998. Alterations of Toxoplasma gondii induced by 2′,3′-dideoxyinosine in vitro. J Parasitol 84: 1055-1059.